List of Poster Presentations

List of Poster Presentations

  1. STRUCTURAL INVESTIGATION OF PROTEIN Z MUTATIONS WITHIN THE EXON 8 IN PATIENTS WITH FETAL LOSSES; Caliandro R, Nico G, Tiscia GL, De Stefano V, Rossi E, Za T, Favuzzi G, Cappucci F, Fischetti L, Colaizzo D, Giuliani F, Grandone E; Italy
  2. UNDERLYING BLEEDING DISORDERS IN PATIENTS ARE EQUALLY IMPORTANT IN MENORRHAGIA WITH AND WITHOUT GYNAECOLOGICAL ABNORMALITIES; Knol HM, Mulder AB, Bogchelman DH, Kluin-Nelemans HC, van der Zee AGJ, Meijer K; the Netherlands
  3. PLASMA FREE DNA AND CIRCULATING NUCLEOSOMES: PRELIMINARY DATA IN NORMAL AND PATHOLOGIC PREGNANCIES; Bouvier S, Grandemange L, Mousty E, Ripart-Neveu S, Marès P, Cochery-Nouvellon E, Mercier E, Gris J-C; France 
  4. HOMOCYSTEINE LEVELS IN PRETERM NEONATES - THE IMPACT OF GENETIC AND ENVIRONMENTAL FACTORS; Simchen MJ, Maayan-Metzger A; Lubetsky A; Kuint J; Rosenberg N; Kuperman A; Sela B-A, Kenet G; Israel
  5. BLEEDING TENDENCY IN SWEDISH CARRIERS OF HAEMOPHILIA A AND B; Anna Olsson, Fariba Baghaei,Erik Berntorp, Margareta Hellgren; Sweden
  6. POLYMORPHISMS OF PLACENTAL ALKALINE PHOSPHATASE GENE ARE ASSOCIATED WITH RECURRENT PREGNANCY LOSS; Bouvier S, Vatin M, Bellazi L, Montagutelli X, Laissue P, Ziyyat A, Serres C, Dieudonné MN, de Mazancourt P, Mornet E, Vaiman D, Gris J-C; France
  7. PREGNANT WOMEN WITH MECHANICAL PROSTHETIC HEART VALVES - WHICH ANTICOAGULANT IS BEST?; Wilkins I, Yatim NL, Ciantar E; United Kingdom
  8. POLYCYSTIC OVARY SYNDROME: INFLUENCE OF BMI AND INSULIN RESISTANCE ON TROMBIN GENERATION IN PLASMA; Aziz M, Sidelmann JJ, Faber J, Wissing ML,  Skouby SO; Denmark
  9. LOCAL BODY TEMPERATURE AS A FACTOR OF THROMBOSIS AND EMBOLISM IN INTRAVENOUS INJECTIONS; Urakov AL, Urakova NA, Kasatkin AA; Russia
  10. VKORC1 GEN POLIMORPHISMS DISTRIBUTION FEATURES IN NATIVE POPULATION OF EUROPEAN RUSSIA FAR NORTH; Vorobyova NA, Belova NI, Lavrinov PA; Russia 
  11. THE DIFFERENCE OF HOMOCYSTEINE PLASMA IN ACUTE MYOCARDIAL INFARCTION DEPENDING ON GENETIC POLYMORPHISMS OF THE ENZYME METHYLTETRAHYDROFOLATREDUCTAZA; Vorobjeva NA, Mukhina PN, Belyakova IV; Russia
  12. ABOUT HEMOSTASIS SYSTEM GENES POLYMORPHISMS IN PATIENTS WITH ACUTE ISCHEMIC STROKE; Vorobyeva NA, Shemaekina NI; Russia
  13. INFLUENCE   PHARMACOGENETICS ANALYSIS ON ADEQUACY AND SAFETY OF THERAPY BY INDIRECT ANTICOAGULANTS AT INHABITANTS OF NORTHWEST REGION OF THE RUSSIAN FEDERATION; Vorobyeva NA, Rogozina AS, Lavrinov PA, Vorobyeva AI; Russia
  14. PHARMOCOSENSITIVITY FEATURES OF INDIRECT ANTICOAGULANTS; Rogozina A, Vorobyeva N; Russia
  15. HEMOSTATIC STATUS OF WOMEN TAKING COMBINED ORAL CONTRACEPTIVES; Gamyrkina DR, Vorobyova NA; Russia
  16. HEREDITARY FACTORS OF THE RISK OF DEEP VENOUS [DEEP VEIN] THROMBOSIS; Trapeznikova E, Vorobyeva N; Russia
  17. UNEXPLAINED RECURRENT PREGNANCY LOSS IS NOT EXPLAINED BY AN UNDERLYING MATERNAL PROTHROMBOTIC STATE; Bennett SA, Bagot CN, Appiah A, Johns J, Ross J, Roberts LN, Patel RK,  Arya R; United Kingdom
  18. ROTATIONAL THROMBOELASTOMETRY IS UNHELPFUL IN WOMEN WITH UNEXPLAINED RECURRENT PREGNANCY LOSS; Bennett SA, Bagot CN, Appiah A, Johns J, Ross J, Roberts LN, Patel RK, Arya R; United Kingdom
  19. FACTOR V LEIDEN AS RISK FACTOR FOR PERINATAL STROKE – A CASE REPORT; Lima J, Lucas M, Marques S, Carvalhosa G, Telhado C, Neto AS; Portugal
  20. TINZAPARIN USE IN PREGNANCY: A NATIONAL, RETROSPECTIVE STUDY OF THE SAFETY AND EFFICACY PROFILE; Santamaría A, Serra B, Palomo A, López MF, Casellas M, Ferreiro M, Portabella E, Fontcuberta J; Spain
  21. MENORRHAGIA CAUSED BY BLEEDING DISORDERS ; Djukic S, Andjelkovic N, Djukic A, Antovic JP; Serbia & Sweden
  22. RISK OF RECURRENCE DURING PREGNANCY AFTER A FIRST VTE: A FRENCH COHORT; Le Moigne E, Delluc A, Daoudal A, Nowak E, Mottier D, Le Gal G; France
  23. RISK OF RECURRENT VENOUS THROMBOEMBOLISM AMONG YOUNG WOMEN AFTER A FIRST EVENT WHILE EXPOSED TO OESTROGEN CONTRACEPTION VERSUS NOT EXPOSED TO: A COHORT STUDY; Le Moigne E, Delluc A, Le Bihan D, Nowak E, Mottier D, Le Gal G, France
  24. A RETROSPECTIVE REVIEW OF RISK FACTORS FOR THROMBOSIS IN WOMEN PRESENTING WITH VENOUS THROMBOEMBOLISM (VTE) DURING PREGNANCY AND THE PUERPERIUM; Mpouzouki A, Bowles L, Beski S, MacCallum P
  25. ADRENOMEDULLIN IS ASSOCIATED WITH VON WILLEBRAND FACTOR ACTIVITY IN NON-PREGNANT BUT NOT IN PREGNANT WOMEN; Pöyhönen-Alho M, Lassila R, Joutsi-Korhonen L, Nicholls G, Kaaja R; Finland
  26. FREQUENCY OF THROMBOPHILIA IN FEMALES WITH STROKE IN ASSOCIATION WITH ORAL CONTRACEPTIVE USE ; Dulíček P, Košťál M, Sadílek P, Beránek M ; Czech Republic
  27. A MALE OR FEMALE FAMILY HISTORY OF VTE; DOES IT INFLUENCE HORMONE-RELATED VTE RISK?; van Vlijmen EFW, Veeger NJGM, Middeldorp S, Hamulyák K, Prins MH, Büller HR, Meijer K; the Netherlands
  28. PREVALENCE OF FACTOR V LEIDEN AND PROTHROMBIN GENE MUTATION G20210A IN WOMEN WITH RECURRENT PREGNANCY LOSS; Vasilakos K, Delkos D, Kydonopoulou K, Papadakis E, Tsioni K, Rousso D, Mandala E; Greece
  29. UNUSUAL D-DIMER ELEVATION IN A 49-YEAR-OLD TWIN GESTATION WOMAN FOLLOWING IVF; Mandala E, Kydonopoulou K, Vasilakos K, Vaitsi V, Tsioni K, Agorastos T ; Greece
  30. LIPOPROTEIN (A) AS A THROMBOPHILIC RISK FACTOR FOR RECURRENT PREGNANCY LOSS; Weidensee S, Demuth St, Schleussner E; Germany
  31. HIGHER THROMBOEMBOLIC RISK IS NO PREDICTOR FOR PREGNANCY LOSS; Schleussner E, Korpas G, Michels W, Bauersachs R for the ETHIG Investigator Group; Germany
  32. SELECTED ASPECTS OF THE ANTITHROMBOTIC PROPHYLAXIS IN PREGNANT WOMEN WITH CONGENITAL THROMBOPHILIAS ; Kvasnička T ; Czech RepubliC
  33. SEX SPECIFIC RISK FACTORS FOR VTE RECURRENCE. LONG TERM FOLLOW-UP, ANALYSIS OF A SINGLE COHORT OF PATIENTS; Theocharidou D, Papadakis E,  Banti A, Karagianni A, Papageorgiou V, Papadopoulos V, Tsimirika K, Efraimidou S, Kaltsounis G, Georgiou E, Kioumi A; Greece
  34. CLINICAL CHARACTERISTICS OF THE FIRST THROMBOSIS PROCESS AMONG YOUNG WOMEN AND THOSE OVER 45; Kovac M, Mitic G, Mikovic Z, Mandic V, Rakicevic L, Djordjevic V, Radojkovic D; Serbia
  35. ESTROGEN AGONISTS SIGNIFICANTLY DOWNREGULATE TFPI EXPRESSION IN AN ERΑ EXPRESSING BREAST CANCER CELL LINE; Ali HO, Stavik B, Dørum E, Iversen N, Sandset PM, Skretting G; Norway
  36. CHANGES IN PLASMA LEVELS OF FACTOR VIIa-ANTITHROMBIN COMPLEX DURING NORMAL PREGNANCY AND IN PRE-ECLAMPSIA; Spiezia L, Visentin S, Radu C, Bon M, Woodhams B, Cosmi E, Simioni P; Italy & France 
  37. IS FREE TFPI LOW PLASMA LEVELS A NEW RISK FACTOR IN WOMEN WITH CORONARY ARTERY DISEASE? Skoura M, Xanthopoulos A, Geladaki B, Theofanakis H, Paraskevopoulou E, Patsilinakos S, Paraskevopoulou P; Greece
  38. PERINATAL THROMBOSIS AND INHERITED PROTHROMBOTIC DISORDERS; Lucas M, Marques S, Lima J, Rodrigues A, Carvalhosa G, Neto AS; Portugal
  39. PROSTHETIC MECHANICAL VALVES AND PREGNANCY: A SINGLE CENTER EXPERIENCE; Kozak M, Vižintin Cuderman T, Štalc M; Slovenia
  40. NO INCREASED FIBRINOLYSIS IN WOMEN WITH MENORRHAGIA; Wiewel-Verschueren S, Knol HM, Lisman T, Bogchelman DH, Kluin-Nelemans HC, van der Zee AGJ, Mulder AB, Meijer K; the Netherlands
  41. MANAGEMENT OF PATIENTS WITH HHT DURING PREGNANCY; Byrne J, Murphy K; Ireland
  42. THROMBOPROPHYLAXIS DURING PREGNANCY IN PATIENTS WITH HIGH RISK FOR VENOUS THROMBOEMBOLISM; Björgvinsdotttir A, Sporrong T, Hagman A, Hellgren M; Sweden
  43. PREECLAMPSIA: PLATELET ACTIVATION, PLATELET-LEUKOCYTE AGGREGATES AND TISSUE FACTOR EXPRESSION ASSESSMENT; Freitas LG, Carvalho MG, Martins-Filho OA, Sathler-Avelar R; Dusse LMS; Brazil
  44. PLASMINOGEN ACTIVATOR INHIBITOR 1: ASSOCIATIONS WITH METABOLIC AND PROINFLAMMATORY FACTOR IN POLYCYSTIC OVARY SYNDROME WOMEN; Sales MF, Sóter MO, Candido AL, Fernandes AP, Sousa MO, Ferreira ACS, Dusse LMS, Ferreira CN, Gomes KB; Brazil
  45. CIRCULATING LEVELS OF SOLUBLE ENDOGLIN (CD105) IN MATERNAL PLASMA IN PREECLAMPSIA; Perucci LO, Gonçalves Freitas L, Carvalho Godoi L, Nessralla Alpoim P, Pinheiro MB, Gomes KB, Dusse LMS, de Sousa LP; Brazil
  46. INTRAPLATELET CYCLIC GUANOSINE MONOPHOSPHATE (cGMP) ASSESSMENT IN LATE AND EARLY SEVERE PREECLAMPSIA; Nessralla Alpoim P, Carvalho Godoi L, Pinheiro MB, Gonçalves Freitas L, Borges KB, Dusse LMS; Brazil
  47. FACTOR VII, FACTOR VIIa AND FACTOR VIIa-ANTITHROMBIN ASSESSEMENT IN EARLY AND LATE SEVERE PREECLAMPSIA; Carvalho GL, Freitas LG, Alpoim PN, Pinheiro MB, Gomes KB, Dusse LMS; Brazil
  48. SEVERE PREECLAMPSIA: RELATIONSHIP BETWEEN HEMOSTASIS AND INFLAMMATION; Pinheiro MB, Martins-Filho OA, Carvalho Godoi L, Nessralla Alpoim P, Freitas LG, Mota APL, Carvalho MG, Gomes KB; Dusse LMS; Brazil
  49. SEVERE PREECLAMPSIA: ASSOCIATION OF GENES POLYMORPHISMS AND MATERNAL CYTOKINES PRODUCTION; Pinheiro MB, Gomes KB, Ronda CRSC, Guimarães GG, Godoi LC, Teixeira-Carvalho A, Martins-Filho OA, Dusse LM; Brazil 
  50. POST-PARTUM HAEMORRHAGE INDUCED HYPERFIBRINOLYSIS; Ducloy-Bouthors A-S, Duhamel A, Tournoys A, Prado-Dupont A, Debize G, Peneau E, Jude B, Vallet B, De Prost D, Huissoud C, Susen S; France
  51. GLANZMANN’S THROMBASTHENIA IN PREGNANCY – A CASE REPORT; Meghan K, Ryan K, Regan C, Byrne B, Lynch C; Ireland
  52. RETRIEVABLE INFERIOR VENA CAVA (IVC) FILTERS IN PREGNANCY – A CASE SERIES AND REVIEW OF THE LITERATURE; Prem P, Maher N, Ryan K, Lynch C, Regan C, Byrne B; Ireland
  53. IVC THROMBOSIS PRECEDING PREGNANCY – TWO UNUSUAL CASES; Maher N, Paramanathan P, Ryan K, Lynch C, Byrne B, Regan C; Ireland
  54. HEMOSTATIC MARKERS AND SLEEP QUALITY AMONG SHIFT WORK AND DAY WORK FEMALE NURSES; Saharov G, Nadir Y, Keren A, Brenner B, Shochat T; Israel
  55. THE CIRCULATING ENDOTHELIAL CELLS LEVEL AND CORONARY HEART DISEASE IN WOMEN; Sirotkina O, Feoktistova V, Laskovets A, Leonova I, Gaykovaya L, Boldueva S, Vavilova T; Russia
  56. MOLECULAR MECHANISMS AND DIFFERENT CLINICAL MANIFESTATIONS OF APS; Khizroeva DK, Bitsadze VO, Makatsariya AD; Russia
  57. IVF - GENETIC AND ACQUIRED THROMBOPHILIA; Khizroeva D, Bitsadze VO, Makatsariya AD, Stuleva N; Russia
  58. ANTIPHOSPHOLIPID ANTIBODIES AND PROGESTERONE DEFICIENCY; Khizroeva DKh, Bitsadze VO, Andreeva MD, Shakhovskaya E; Russia
  59. LMWH IN PROPHYLAXIS OF REPEATED COMPLICATIONS OF MULTIPLE PREGNANCY IN WOMEN WITH THROMBOPHILIA; Makatsariya AD, Panfilova O, Bitsadze V; Russia
  60. PROPHYLAXIS OF RECURRENT PLACENTAL ABRUPTIONS IN MULTIPLE PREGNANCY; Panfilova O, Makatsaria N; Russia
  61. BIOSIMILAR LMWH HEMAPAXAN (ENOXAPARIN NATRIUM) IN PREVENTION OF REPEATED THROMBOSES AT PREGNANT WOMEN WITH TROMBOPHILIA; Bitsadze V, Panfilova O, Makatsaria N; Russia
  62. MASSIVE OBSTETRIC BLEEDINGS AND PATHOLOGY OF HEMOSTASIS SYSTEM; Makatsariya AD; Russia
  63. CLINICAL SIGNIFICANCE OF DETECTION OF GENETIC AND ACQUIRED FORMS OF THROMBOPHILIA IN PREOPERATIVE PERIOD; Vorobiev AV; Russia
  64. BIOSIMILAR LMWH HEMAPAXAN IN PROPHYLAXIS OF THROMBOTIC COMPLICATIONS IN CANCER PATIENTS; Vorobiev AV; Russia
  65. GENETIC AND ACQUIRED FORMS OF THROMBOPHILIA AS A RISK FACTOR FOR HORMONE REPLACEMENT THERAPY; Kvikvinia IZ; Russia
  66. THE RATE OF DIC AND THROMBOPHILIA DURING CHEMOTHERAPY AND ITS PREVENTION APPROACHES IN OVARIAN CANCER PATIENTS; Vorobiev AV; Russia
  67. FACTOR V LEIDEN MUTATION AND SPLANCHNIC VEIN THROMBOSIS (CLINICAL CASE REPORT); Titsenko, Bitsadze V, Makatsaria A; Russia
  68. GYNECO-OBSTETRICAL BLEEDING IN A COHORT OF FEMALE PATIENTS WITH FACTOR XI DEFICIENCY - A REPORT FROM FRENCH CANADA; Vezina C, David M, Nguyen KA, Thibeault C, Winikoff R; Canada
  69. COAGULOPATHIES EARLY IN POSTPARTUM HAEMORRHAGE; THROMBOELASTOGRAPHY AND HAEMOSTATIC LABORATORY ANALYSES; Karlsson O, Henriksson B-Å, Jeppsson A, Hellgren M, Sweden
  70. SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME IN PREGNANCY: ASSESSING THE IMPORTANCE OF A MULTIDISCIPLINARY CONSULTATION; Neves JP, Carvalho RG, Dias C, Guimarães M; Portugal
  71. THE PBAC-SCORE IS AN EASY TOOL TO QUANTITY MENSTRUAL BLOOD LOSS IN WOMEN; Halimeh S, Rott H, Kappert G, Siebert M; Germany
  72. RECURRENT SPONTANEOUS ABORTION IN WOMEN WITH BLEEDING DISORDERS; Halimeh S, Rott H, Kappert G, Siebert M; Germany
  73. MULTITRANSFUSION IN RELATION TO POSTPARTUM HAEMORRHAGE; Edwards H, Wikkelsø A, Afshari A, Langhoff-Roos J, Møller A, Stensballe J; Denmark 
  74. ANTIPHOSPHOLIPID ANTIBODIES: INCIDENCE AND IMPLICATIONS IN WOMEN WITH IMMUNE THROMBOCYTOPENIC PURPURA; Djunic I, Jovanovi J, Suvajdzic-Vukovic N, Bonaci-Nikolic B, Novkovic A, Vidovic A, Tomin D; Serbia
  75. PREVALENCE OF SEVERE DYSMENORRHEA AMONG WOMEN WITH CONSECUTIVE FIRST-TRIMESTER MISCARRIAGES; Hoirisch Clapauch S; Brazil
  76. EARLY NEONATAL HYPOGLYCEMIA PREDICTION ACCORDING TO MATERNAL PARAMETERS; Hoirisch-Clapauch S, Porto MAS; Brazil
  77. CLINICAL VALUE OF DETERMINATION OF APC-RESISTANCE AND PROTEIN C GLOBAL TEST IN OBSTETRIC PRACTICE; Mikhailidi IA, Santrosyan IK; Russia
  78. PREGNANCY-ASSOCIATED CHANGES OF CLOTTING AND METABOLIC PARAMETERS IN WOMEN WITH HISTORY OF INFERTILITY; Lodigiani C, Banfi E, Ferrazzi P, Librè L, Quaglia I, Morenghi E, Rota LL; Italy
  79. LONG TERM USE OF LOW MOLECULAR WEIGHT HEPARIN DURING PREGNANCY DOES NOT AFFECT  POSTPARTUM BONE MINERAL DENSITY; Mitic G, Novakov-Mikic A,  Novakovic-Paro J, Popov D, Novakovic-Anucin S, Gnip S, Canak V, Spasic D, Kovacev-Zavisic B; Serbia
  80. RISK OF VENOUS THROMBOSIS AFTER CESAREAN SECTIONS: A META-ANALYSIS; Blondon M, Harrington L, Hoppe KK, Righini M, Boehlen F, Smith NL, Bounameaux H; USA & Switzerland
  81. INTERACTIONS BETWEEN GENETIC POLYMORPHISMS AND ORAL HORMONE THERAPY ON THE RISK OF VENOUS THROMBOSIS; Blondon M, Wiggins KL, Harrington L, Li G, McKnight B, Psaty BM, Smith NL; USA & Switzerland
  82. CORRELATION OF 20210G>A AND 19911A>G PROTHROMBIN GENE POLYMORPHISMS WITH THE RISK OF THE FIRST TRIMESTER RECURRENT MISCARRIAGES; Barlik M, Seremak-Mrozikiewicz A, Kurzawińska G, Drews K, Kraśnik W; Poland
  83. RISK STRATIFICATION SCALE FOR PREGNANT WOMEN AT RISK FOR THROMBOTIC EVENTS: A SINGLE-CENTRE EXPERIENCE; Pestana I, Salselas A, Andrade J, Guimarães M; Portugal
  84. ENOXAPARINE VERSUS RIBAROXABAN: COMPARISON OF THERAPEUTIC ADHESION IN AMBULATORY PATIENTS; Marcos JM, Ramalhinho AC, Amantegui P, Ribeiro MJ, Morgado M, Fonseca O; Portugal
  85. RELEVANCE OF AGE AS A RISK FACTOR FOR RECURRENCE AFTER FIRST VENOUS THROMBOEMBOLIC EVENT IN WOMEN; Mitic G, Kovac M; Serbia 
  86. ANTITHYROID ANTIBODIES IN RECURRENT MISCARRIAGES; Lefkou E, Adamidou D, Rakitzi P, Kakanis S, Theodoridou A, Theodoridou S, Mamopoulos A, Papaioannou G; Greece
  87. PREVALENCE OF ANTIPHOSPHOLIPID ANTIBODIES IN WOMEN WITH STILLBIRTHS AND NORMAL EMBRYO KARYOTYPES; Lefkou E, Mamopoulos A, Vakalopoulou S, Pleki S, Pleki A, Adamidou D, Daglis T,  Papaioannou G; Greece
  88. INHERITED THROMBOPHILIA IN WOMEN WITH STILBIRTHS; Lefkou E, Adamidou D,  Vassilakos K,  Pleki A, Pleki S,  Mamopoulos A, Daglis T,  Papaioannou G, Mandala E; Greece
  89. UPPER LIMB DEEP VEIN THROMBOSIS IN PREGNANCY (ULDVT): CASE REPORT OF 4 PATIENTS; Casellas M, Capote S, Correa A, Pérez-Ceresuela F, Cabero L; Spain
  90. OBSTETRIC OUTCOMES IN PATIENTS WITH PREVIOUS VENOUS THROMBOEMBOLIC DISEASE (VTD); Capote S, Casellas M, Pérez-Ceresuela F, Correa A, Cabero L; Spain
  91. RECURRENCE OF VENOUS THROMBOEMBOLIC DISEASE (VTD) IN PREGNANCY; Casellas M, Capote S, Correa A, Pérez-Ceresuela F, Cabero L; Spain
  92. IS INHERITED THROMBOPHILIA (IT) ASSOCIATED WITH PLACENTAL VASCULAR COMPLICATIONS (PVD) IN PATIENTS TREATED WITH LOW-MOLECULAR-WEIGHT HEPARIN (LMWH)?; Capote S, Casellas M, Correa A,  Pérez-Ceresuela F, Cabero L; Spain
  93. IMPACT OF HORMONE TREATMENT ON THROMBIN GENERATION IN INFERTILE WOMEN UNDERGOING ARTIFICIAL REPRODUCTIVE TECHNIQUES ; d'Argent EM, Comtet M, Ketatni H, Galea V, Bouffard S, Antoine J-M, Vandreden P, Rousseau A, Elalamy I, Gerotziafas GT; France
  94. ANTITHROMBOTIC TREATMENT IN PREGNANT WOMEN WITH HIGH THROMBOTIC RISK SITUATIONS; Grand B, González Alcántara M, Voto G, Orti J, Lapidus A, Voto LS; Argentina
  95. MANAGEMENT OF INHERITED BLEEDING DISORDERS (IBD) IN PREGNANT WOMEN IN A PUBLIC HOSPITAL; Grand B, Gonzalez Alcantara M, Voto G, Orti J, Lapidus A, Voto LS; Argentina
  96. STUDY OF THE CORRELATION BETWEEN FACTOR V-LEIDEN AND RESISTANCE TO ACTIVATED PROTEIN C IN WOMEN WITH A HISTORY OF RECURRENT PREGNANCY LOSS; Vasilakos K, Kydonopoulou K, Delkos D, Pavlou D, Papadakis E, Rousso D, Mandala E; Greece
  97. VON WILLEBRAND’S DISEASE AND RECURRENT 1ST TRIMESTER MISCARRIAGE: SUCCESSFUL OUTCOME AFTER ADMINISTRATION OF VON WILLEBRAND FACTOR; Vakalopoulou S, Mamopoulos A, Lefkou E, Moka E, Mavromatidis G, Garipidou V, Rousso D; Greece
  98. VENOUS PARANEOPLASTIC THROMBOEMBOLISM [(DEEP VENOUS THROMBOSIS (DVT) AND PULMONARY EMBOLISM (PE)] ASSOCIATED WITH NEW THERAPEUTICAL TREATMENTS IN WOMEN-A RETROSPECTIVE SINGLE CENTER EXPERIENCE; García-Consuegra R, Santamaría A, García-Cadenas I, Chiodini A, Del Villar C, Vilalta N, Fontucuberta J; Spain
  99. THE EFFECTS OF LOW MOLECULAR WEIGHT HEPARIN ON TROPHOBLASTS; Rimon E, Kupferminc M; Israel
  100. PROTEIN C GLOBAL ASSAY IN THE EVALUATION OF INFERTILE WOMEN UNDERGOING IVF-ET TREATMENT; Younis JS, Ben-Ami M, Izhaki I, Sarig G, Brenner B; Israel